SG Americas Securities
AMED

SG Americas Securities’s Amedisys AMED Stock Holding History

SG Americas Securities’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-15,000
Closed -$90K – 2820
2024
Q1 		$90K Buy
+15,000
New +$1.41M ﹤0.01% 2593

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

SG Americas Securities's AMED Position: Q3 2025 in Review

SG Americas Securities sold out of Amedisys (AMED) in Q3 2025, closing a stake of 41,966 shares — an estimated $4.13M sold.

SG Americas Securities first reported a position in AMED in Q3 2013 and held it in 39 quarters. The position peaked at $19M in Q3 2024. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • SG Americas Securities reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • SG Americas Securities sold 41,966 Amedisys shares in Q3 2025, an estimated $4.13M.
  • SG Americas Securities first reported a position in Amedisys in Q3 2013 and held it in 39 quarters.
  • SG Americas Securities's Amedisys position peaked at $19M in Q3 2024.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on SG Americas Securities's 13F filing for Q3 2025, filed 23 Oct 2025.